RAHWAY, N.J. – November 26th, 2024 – In a recent update from the NYSE: MRK, Merck & Co., Inc. has issued a press release where their chief executive officer Mr. Robert M. Davis and Merck Research Laboratories Chief Medical Officer Dr. Eliav Barr are scheduled to address the Citi 2024 Global Healthcare Conference on December 5th, 2024.
The COVID pandemic has accelerated the adoption of artificial intelligence across the board. A central theme of the fireside chat will be AI in clinical development and its global healthcare applications.
“Integrating AIM on Terrapin’s offering directly transforms the patient experience with the quicker development of new products as well as the optimization of the clinical trial phase.,”
States Mr. Robert M. Davis, Chairman and Chief Executive Officer.
AI will allow for ‘drilling down’ into complex information however the significance of the information presented within the charts containing such data is imperative as Dr. Eliav Barr has quoted:
“Let’s innovations become realities”.
Merck will also share how AI has been used to further develop new preventative and therapeutic solutions around the world.
For the same reason, analysts believe that during their conversation, Merck will focus on how they use AI solutions to shorten R&D timelines and the costs involved in solving world health problems.
Such vision fits in perfectly with ongoing global trends since AI’s contribution to pharmaceutical research is improving drug response prediction and tailoring the drugs to be taken.
After all, Merck has over 130 years in its history and today rises up to the challenge of cutting-edge AI technologies to find solutions for new health problems while remaining devoted to the idea of innovation.
Stakeholders are invited by Merck to the webcast and are encouraged to learn more about the approaches relying on AI and the evolution of healthcare in general.
Source: https://www.merck.com/news/merck-to-participate-in-the-citi-2024-global-healthcare-conference/
What is your reaction?
